1.66
0.01 (0.61%)
| Penutupan Terdahulu | 1.65 |
| Buka | 1.64 |
| Jumlah Dagangan | 42,122 |
| Purata Dagangan (3B) | 64,767 |
| Modal Pasaran | 42,164,784 |
| Harga / Jualan (P/S) | 256.05 |
| Harga / Buku (P/B) | 2.97 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2025 - 8 Aug 2025 |
| Margin Operasi (TTM) | -37,468.63% |
| EPS Cair (TTM) | 3.38 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -51.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -19.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 26.43% |
| Nisbah Semasa (MRQ) | 2.45 |
| Aliran Tunai Operasi (OCF TTM) | -19.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.33 M |
| Pulangan Atas Aset (ROA TTM) | -135.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -485.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Serina Therapeutics, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | -5.0 |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -1.56 |
|
Serina Therapeutics, Inc. operates as a pharmaceutical company that develops drugs to treat neurological diseases, cancer, and pain. The company develops a pipeline of partnered programs applying POZ platform to cancer, pain, refractory epilepsy, and movement disorders, such as Parkinson's disease and restless leg syndrome. Its pipeline includes SER-214, a solution for Parkinson's disease/restless leg syndrome; SER-226, a post-operative pain management solution; SER-228 for refractory epilepsy; SER-232 for chemotherapy-induced nausea and vomiting; and polymer poly (2-oxazoline) or POZ drug delivery polymer technology. Serina Therapeutics, Inc. was incorporated in 2006 and is based in Huntsville, Alabama. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 63.85% |
| % Dimiliki oleh Institusi | 3.37% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Waverly Advisors, Llc | 30 Jun 2026 | 67,492 |
| Keel Point, Llc | 30 Jun 2026 | 21,508 |
| Avidian Wealth Enterprises, Llc | 30 Sep 2026 | 18,800 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |